Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors

被引:16
作者
Wang, Ziqian [1 ]
Xu, Wenjie [1 ]
Song, Ting [2 ]
Guo, Zongwei [2 ]
Liu, Lu [1 ]
Fan, Yudan [2 ]
Wang, Anhui [1 ]
Zhang, Zhichao [1 ]
机构
[1] Dalian Univ Technol, Sch Chem, State Key Lab Fine Chem, Dalian 116012, Peoples R China
[2] Dalian Univ Technol, Sch Life Sci & Technol, Dalian, Peoples R China
基金
中国国家自然科学基金;
关键词
Fragment-based drug design; Ligand efficiency; Mcl-1; inhibitor; p1; pocket; Selective; BCL-2; FAMILY; DRUG DESIGN; ABT-737; DISCOVERY; PROTEINS; POTENT; ANTAGONISTS; RESISTANCE; APOPTOSIS; BIG;
D O I
10.1002/ardp.201600251
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Based on a known selective Mcl-1 inhibitor, 6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-1H-indole-2-carboxylic acid, we applied a fragment-based approach to obtain new molecules that extended into the p1 pocket of the BH3 groove and then exhibited binding selectivity for the Mcl-1 over the Bcl-2 protein. After we deconstructed the 1H-indole-2-carboxylic acid from the parental molecule, a benzenesulfonyl was substituted at the 1-position to adopt a geometry preferred for accessing the p1 pocket according to the binding mode of the parental molecule identified by X-ray crystallography. A linear relationship between the free energy of ligand binding (Delta G) and the count of non-hydrogen heavy atoms (HAC) was maintained during the molecular growing to occupy the p1 pocket. Finally, we not only obtained compound 12 with a 7.5-fold selectivity to Mcl-1 (K-i = 0.48 mu M by fluorescence polarization) over Bcl-2 (K-i = 3.6 mu M), but also provided evidence that additional occupation of the p1 pocket is more favorable for Mcl-1 than for Bcl-2 binding, and contributes more to Mcl-1 inhibition than occupation of the p2 pocket. Compound 12 exhibited a selective killing ability on Mcl-1-dependent cancer cells.
引用
收藏
页数:12
相关论文
共 50 条
[41]   Design, synthesis and structure-activity relationship studies of morpholino-1H-phenalene derivatives that antagonize Mcl-1/Bcl-2 [J].
Li, Xiangqian ;
Liang, Xiaomeng ;
Song, Ting ;
Su, Pengchen ;
Zhang, Zhichao .
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (21) :5738-5746
[42]   Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins [J].
de Araujo, Aline D. ;
Lim, Junxian ;
Wu, Kai-Chen ;
Xiang, Yibin ;
Good, Andrew C. ;
Skerlj, Renato ;
Fairlie, David P. .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (07) :2962-2972
[43]   Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors [J].
Johannes, Jeffrey W. ;
Bates, Stephanie ;
Beigie, Carl ;
Belmonte, Matthew A. ;
Breen, John ;
Cao, Shenggen ;
Centrella, Paolo A. ;
Clark, Matthew A. ;
Cuozzo, John W. ;
Dumelin, Christoph E. ;
Ferguson, Andrew D. ;
Habeshian, Sevan ;
Hargreaves, David ;
Joubran, Camil ;
Kazmirski, Steven ;
Keefe, Anthony D. ;
Lamb, Michelle L. ;
Lan, Haiye ;
Li, Yunxia ;
Ma, Hao ;
Mlynarski, Scott ;
Packer, Martin J. ;
Rawlins, Philip B. ;
Robbins, Daniel W. ;
Shen, Haidong ;
Sigel, Eric A. ;
Soutter, Holly H. ;
Su, Nancy ;
Troast, Dawn M. ;
Wang, Haiyun ;
Wickson, Kate F. ;
Wu, Chengyan ;
Zhang, Ying ;
Zhao, Qiuying ;
Zheng, Xiaolan ;
Hird, Alexander W. .
ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (02) :239-244
[44]   Substituted 1-methyl-4-phenylpyrrolidin-2-ones - Fragment-based design of N-methylpyrrolidone-derived bromodomain inhibitors [J].
Hilton-Proctor, J. P. ;
Ilyichova, O. ;
Zheng, Z. ;
Jennings, I. G. ;
Johnstone, R. W. ;
Shortt, J. ;
Mountford, S. J. ;
Scanlon, M. J. ;
Thompson, P. E. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 191
[45]   Analysis of Flexibility and Hotspots in Bcl-xL and Mcl-1 Proteins for the Design of Selective Small-Molecule Inhibitors [J].
Yang, Chao-Yie ;
Wang, Shaomeng .
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (04) :308-312
[46]   Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening [J].
Liu, Jian ;
Zhou, Jingxian ;
He, Fengjun ;
Gao, Liang ;
Wen, Yu ;
Gao, Lina ;
Wang, Ping ;
Kang, Di ;
Hu, Lihong .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 192
[47]   Structure-based design of 3-carboxy-substituted 1,2,3,4-tetrahydroquinolines as inhibitors of myeloid cell leukemia-1 (Mcl-1) [J].
Chen, L. ;
Wilder, P. T. ;
Drennen, B. ;
Tran, J. ;
Roth, B. M. ;
Chesko, K. ;
Shapiro, P. ;
Fletcher, S. .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2016, 14 (24) :5505-5510
[48]   Discovery and structure-activity relationship studies of novel Bcl-2/Mcl-1 dual inhibitors with indole scaffold [J].
Zhang, Zhenwei ;
Hou, Linghui ;
Bai, Lijun ;
Pei, Jiying ;
Zhao, Shan ;
Liu, Dan ;
Luan, Shenglin ;
Huang, Min ;
Zhao, Linxiang .
BIOORGANIC CHEMISTRY, 2022, 125
[50]   Synthesis, Anticancer Evaluation and Molecular Docking of Hexahydroquinoline Derivatives as Mcl-1 Inhibitors and Apoptosis Inducers [J].
Teraiya, Nishith ;
Karki, Subhas S. ;
Chauhan, Ashlesha .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (11) :2142-2155